SACCO, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 11
NA - Nord America 5
AS - Asia 1
Totale 17
Nazione #
FR - Francia 8
US - Stati Uniti d'America 5
FI - Finlandia 2
IT - Italia 1
JP - Giappone 1
Totale 17
Città #
Columbus 5
Lappeenranta 2
Milan 1
Tokyo 1
Totale 9
Nome #
Protection against severe COVID-19 after second booster dose of adapted bivalent (original/Omicron BA.4-5) mRNA vaccine in persons ≥ 60 years, by time since infection, Italy, 12 September to 11 December 2022, file c91ca986-5f06-497f-993d-7d3d42c821a7 3
Estimating SARS-CoV-2 infections and associated changes in COVID-19 severity and fatality, file d410a7a7-3038-46fa-8106-d5ae1f57d33f 3
Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: Retrospective cohort study, file 1e09e25a-ba88-4d69-9962-f7763c9ac4b6 2
Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021, file 5f5beba8-996a-490e-bea2-be74509dddc6 2
Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022, file 7674a840-45f0-457d-96db-9e07efa21fa4 2
Relative effectiveness of bivalent Original/Omicron BA.4-5 mRNA vaccine in preventing severe COVID-19 in persons 60 years and above during SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages circulation, Italy, April to June 2023, file 8f94db59-35cd-4871-a5ce-bed4ac578c87 2
Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a retrospective matched cohort study, file 7f031256-2c87-4a37-b0b4-1d523a8a976e 1
Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study, file a7d31e87-fe99-47ed-ac97-b2fc82ad95b5 1
Estimated Effectiveness of a Primary Cycle of Protein Recombinant Vaccine NVX-CoV2373 Against COVID-19, file c241a4e7-64dd-4d35-989c-c3ac238ff488 1
Totale 17
Categoria #
all - tutte 75
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202417 0 0 0 0 0 0 0 0 2 0 15 0
Totale 17